Advancements in AI-driven diagnostics could transform cardiology, enabling autonomous interpretation of up to 80% of cardiac imaging within a decade. David Ouyang, MD, discusses overcoming barriers to running…
NEW YORK (Reuters Health) – The nucleoside reverse transcriptase inhibitors (NRTIs) abacavir and didanosine, and the protease inhibitors (PIs) indinavir and lopinavir-ritonavir, all increase the risk of myocardial…
Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, discusses biomarkers in Alzheimer’s Disease, which are currently used in clinical trials as inclusion…
NEW YORK (Reuters Health) – The incidence of acute kidney injury after transcatheter aortic valve implantation (TAVI) is higher than 10%, a Canadian study shows. As reported in…
NEW YORK (Reuters Health) – Patients with non-ST-segment elevation acute coronary syndrome and elevated troponin T get no long term benefits from early invasive treatment as opposed to…
NEW YORK (Reuters Health) – Magnetic guidewire navigation is feasible in primary percutaneous coronary intervention (PCI), according to results of a noninferiority trial performed in the Netherlands. Moreover,…
NEW YORK (Reuters Health) – Adenosine is less able to convert paroxysmal supraventricular tachycardia (SVT) to sinus rhythm when it’s given within 4 hours of caffeine ingestion, Australian…
NEW YORK (Reuters Health) – Although patients with liver disease often have an increased international normalized ratio (INR), their coagulopathy does not protect against venous thromboembolism (VTE), new…
NEW YORK (Reuters Health) – In patients with ventricular tachycardia (VT) and a previous myocardial infarction, prophylactic VT ablation in advance of defibrillator placement appears to postpone recurrence…
NEW YORK (Reuters Health) – In patients with chronic total coronary occlusions, drug-eluting stents (DES) have better long-term outcomes than bare metal stents, according to a paper from…
NEW YORK (Reuters Health) – Patients treated with high-dose recombinant activated factor VII (rFVIIa) for spontaneous intracerebral hemorrhage face a “small increased risk of what are usually minor…
